Roche’s bispecific antibody, Columvi receives European approval for diffuse large B-cell lymphoma after initial therapy: Basel Tuesday, April 15, 2025, 10:00 Hrs [IST] Roche ann ...

Basel: Roche has announced that the company has received approval from the European Commission for Columvi (glofitamab) in ...

The approval of the Columvi combo, the first bispecific antibody regimen for DLBCL in Europe, follows a conditional marketing ...

The European Commission approves RHHBY's Columvi combo to treat adult patients with diffuse large B-cell lymphoma after ...

The European Commission has approved Roche's Columvi as the first bispecific antibody for the treatment of diffuse large ...

In this interview, Magdalena Corona de Lapuerta, recipient of the Jian-Jian Luan Award for Lymphoma Transplant Research, ...

Researchers have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating ...

Pfizer Inc. has announced the company has discontinued the development of danuglipron (PF-06882961), an oral glucagon-like ...

A Swiss citizen has been abducted in Niger, the Swiss foreign ministry said on Monday on X. The Swiss representation in the capital Niamey is in contact with the local authorities.

More and more unexploded ordnance is being defused in Switzerland. Thanks to over a thousand tips from the public, the army neutralised 273 such munitions last year, 26% more than the long-term ...